Jasper Therapeutics Statistics
Total Valuation
JSPR has a market cap or net worth of $24.04 million. The enterprise value is $16.99 million.
| Market Cap | 24.04M |
| Enterprise Value | 16.99M |
Important Dates
The last earnings date was Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
JSPR has 33.27 million shares outstanding. The number of shares has increased by 71.73% in one year.
| Current Share Class | 33.27M |
| Shares Outstanding | 33.27M |
| Shares Change (YoY) | +71.73% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 2.57% |
| Owned by Institutions (%) | 32.54% |
| Float | 30.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 14.23 |
| P/TBV Ratio | 16.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.19.
| Current Ratio | 1.47 |
| Quick Ratio | 0.93 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -255.05% and return on invested capital (ROIC) is -241.71%.
| Return on Equity (ROE) | -255.05% |
| Return on Assets (ROA) | -113.41% |
| Return on Invested Capital (ROIC) | -241.71% |
| Return on Capital Employed (ROCE) | -1,335.96% |
| Weighted Average Cost of Capital (WACC) | 20.66% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.44M |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.43% in the last 52 weeks. The beta is 3.03, so JSPR's price volatility has been higher than the market average.
| Beta (5Y) | 3.03 |
| 52-Week Price Change | -75.43% |
| 50-Day Moving Average | 0.63 |
| 200-Day Moving Average | 1.13 |
| Relative Strength Index (RSI) | 50.23 |
| Average Volume (20 Days) | 766,962 |
Short Selling Information
The latest short interest is 4.31 million, so 12.96% of the outstanding shares have been sold short.
| Short Interest | 4.31M |
| Short Previous Month | 1.66M |
| Short % of Shares Out | 12.96% |
| Short % of Float | 14.37% |
| Short Ratio (days to cover) | 1.53 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -52.86M |
| Pretax Income | -31.77M |
| Net Income | -31.77M |
| EBITDA | -52.30M |
| EBIT | -52.86M |
| Earnings Per Share (EPS) | -$1.23 |
Balance Sheet
The company has $7.31 million in cash and $270,000 in debt, with a net cash position of $7.04 million or $0.21 per share.
| Cash & Cash Equivalents | 7.31M |
| Total Debt | 270,000 |
| Net Cash | 7.04M |
| Net Cash Per Share | $0.21 |
| Equity (Book Value) | 1.41M |
| Book Value Per Share | 0.05 |
| Working Capital | 3.73M |
Cash Flow
| Operating Cash Flow | -60.33M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 561,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -60.33M |
| FCF Per Share | -$1.81 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
JSPR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -71.73% |
| Shareholder Yield | -71.73% |
| Earnings Yield | -139.39% |
| FCF Yield | -264.70% |
Analyst Forecast
The average price target for JSPR is $7.38, which is 921.60% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.38 |
| Price Target Difference | 921.60% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 4, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jan 4, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |